Stage of the estrous cycle at the time of pregnant mare's serum gonadotropin injection affects pre-implantation embryo development in vitro in the mouse

• Published in: Molecular reproduction and development 2002-07, Vol.62 (3), p.312-319
• Main Authors: Tarín, Juan J., Pérez-Albalá, Sonia, Gómez-Piquer, Vanessa, Hermenegildo, Carlos, Cano, Antonio
• Format: Article
• Language: English
• Subjects: Analysis of Variance; Animals; apoptosis; Apoptosis - drug effects; Biological and medical sciences; Blastocyst; Cell Count; Embryonic and Fetal Development; Embryonic Development; Estrous Cycle - metabolism; Female; Fertilization in Vitro; Fundamental and applied biological sciences. Psychology; gamete biology; Gonadotropins, Equine - pharmacology; Male; Mammalian female genital system; meiosis; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mitosis - drug effects; Mitotic Index; Morphology. Physiology; Oocytes - drug effects; ovulation; ovulatory cycle; Pregnancy; Vertebrates: reproduction
• ISSN: 1040-452X; 1098-2795
• DOI: 10.1002/mrd.10132

The present study aims to analyze in the mouse the effect of the stage of the estrous cycle at the time of pregnant mare's serum gonadotropin (PMSG) injection on fertilization of ovulated cumulus‐enclosed oocytes and later embryo development in vitro to the blastocyst stage. Quality of blastocysts was evaluated by staining and counting of total number of nuclei, mitotic index, percentage of apoptotic nuclei, and cell allocation to the inner cell mass (ICM) and trophectoderm (TE) lineage. Superovulation of hybrid (C57Bl/6JIco female × CBA/JIco male) female mice of 4–6 weeks of age was induced by a priming injection of PMSG at different stages of the estrous cycle followed after a 48‐hr interval by human chrorionic gonadotropin. Our data indicate that injection of PMSG at the estrus phase gives the best outcome whereas injection of PMSG at the diestrus‐1 or diestrus‐2 phase provides the worst results. In fact, (1) total number of oocytes ovulated, number of ovulated oocytes enclosed by cumulus cells, and number of TE cells in day‐5 blastocysts were significantly lower in diestrus‐1 females than in estrus, diestrus‐2 and proestrus mice; (2) percentage of day‐5 blastocysts and total number of cells in day‐5 blastocysts were lower in diestrus‐1 and diestrus‐2 females than in estrus and proestrus mice; and (3) percentage of apoptotic nuclei in day‐5 blastocysts was lower in estrus mice than in diestrus‐1, diestrus‐2, or proestrus females. These data endorse previous studies suggesting that administration of gonadotropins in mice should be synchronized with the innate estrous cycle of females. Mol. Reprod. Dev. 62: 312–319, 2002. © 2002 Wiley‐Liss, Inc.